Document Detail


Hemoperfusion in the treatment of uremia.
MedLine Citation:
PMID:  3912588     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The usefulness of hemoperfusion in ESRD therapy has not yet been proven in long-term studies. This negative assessment of results is not meant to impugn the efforts of the many investigators in this field. Their research has led to the development of sorbent cartridges, which have played a major life-saving role in acute poison therapy. Moreover, many futuristic artificial organs, such as the wearable artificial kidney and the prosthetic liver, will be lineal descendants of early sorbent research and their development will be facilitated further by current and future studies. Surely, for all those who are not prematurely discouraged by the negative results to date, hemoperfusion remains a challenging avenue for clinical innovation.
Authors:
H J Gurland
Related Documents :
17080448 - Treatment of bulimia nervosa: where are we and where are we going?
10914478 - Replication research: a purposeful occupation worth repeating.
6881258 - The foundation. the occupational therapy library: a professional resource.
24891348 - Q&a: brian kennedy on aging and cancer.
22113898 - How will internet use affect the patient? a review of computer network and closed inter...
21368018 - Are we there yet? positioning qualitative research differently.
Publication Detail:
Type:  Historical Article; Journal Article    
Journal Detail:
Title:  Kidney international. Supplement     Volume:  17     ISSN:  0098-6577     ISO Abbreviation:  Kidney Int. Suppl.     Publication Date:  1985 Dec 
Date Detail:
Created Date:  1986-04-03     Completed Date:  1986-04-03     Revised Date:  2006-04-17    
Medline Journal Info:
Nlm Unique ID:  7508622     Medline TA:  Kidney Int Suppl     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S47-9     Citation Subset:  IM; Q    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Charcoal / adverse effects
Combined Modality Therapy
Hemoperfusion* / history
History, 20th Century
Humans
Membranes, Artificial
Middle Aged
Renal Dialysis
Uremia / therapy*
Chemical
Reg. No./Substance:
0/Membranes, Artificial; 16291-96-6/Charcoal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protecting the patient's interest.
Next Document:  Corneal astigmatism following a 2-step scleral incision in cataract operations with implantation of ...